Phase 1 Shingles Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1Phase 2

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

vaccine preventable diseasesHerpes ZosterShingles

Dynavax Technologies Corporation764 enrolled13 locationsNCT06569823

Completed

Phase 1

WNTR-VZV-001: A Phase Ib, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Tolerability of Solexan™ when Administered Topically to Acute Varicella Zoster Virus (Shingles) Lesions.

Herpes ZosterShingles

Wintermute Biomedical30 enrolled1 locationACTRN12624000075583

Completed

Phase 1

Comparative assessment of the absorption of a generic formulation of 2-(diethylamino-N-(2,6-dimethylphenyl)acetamide 5% w/w trandermal patch against the innovator 32-(diethylamino-N-(2,6-dimethylphenyl)acetamide 5% w/w trandermal patch conducted under fasting conditions in healthy male and female volunteers.

2-(diethylamino-N-(2,6-dimethylphenyl)acetamide is used as a local anaesthetic. It is indicated for symptomatic relief of nerve pain associated with medically diagnosed post-herpetic neuralgia (post-shingles pain).

Zenith Technology Corporation Limited24 enrolled1 locationACTRN12622000141741

Not Yet Recruiting

Phase 1

Treatment of acute pain after shingles with vitamin D cream

Acute herpes zoster (shingles)

Jim Bartley10 enrolled1 locationACTRN12609001014246